Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

UBS Lifts JNJ Price Target to $320 Amid Remarkable Share Surge

Guavy AI Editorial Team
Instruments
JNJ
Share

UBS has raised its price target for Johnson & Johnson to $320 from $280, while maintaining a Buy rating on the stock.

The increase of $40 represents a significant boost, coming as the company's shares currently trade at $271.19.

This remarkable 55.73% return over the past year has some analysts warning that JNJ may be overvalued, trading near its 52-week high of $276.47.

UBS analyst Michael Yee issued the updated price target, but the firm's Buy rating remains unchanged.

More on Stocks

Stocks just now

DOJ Expands Beef Price Investigation to Major Retailers

Stocks 1m ago

Greenleaf Trust Sells Small Stake in Amazon.com Amid Ongoing FTC Lawsuit

Stocks 2m ago

Amazon September Bestsellers: Essential Products for a Smooth Transition

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy